Lauren Sadowsky, MD
Dermatology · San Antonio, TXNPI 1477172633
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for dermatology clinicians in TX, where the typical reported total is $4,085.
Across 160 payments — averaging $26.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$865
- AbbVie$588
- Incyte Corporation$546
- Galderma Laboratories, L.p.$299
- Lilly USA, LLC$288
- UCB, Inc.$184
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,82591%
- Education$3779%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 25 | $865 |
| AbbVie | 16 | $588 |
| Incyte Corporation | 17 | $546 |
| Galderma Laboratories, L.p. | 18 | $299 |
| Lilly USA, LLC | 12 | $288 |
| UCB, Inc. | 8 | $184 |
| E.r. Squibb & Sons, L.L.C. | 7 | $165 |
| Amgen | 6 | $159 |
| Novartis | 7 | $131 |
| Arcutis Biotherapeutics, Inc. | 6 | $124 |
| LEO Pharma Inc. | 5 | $116 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $111 |
| Sanofi | 5 | $106 |
| Regeneron Healthcare Solutions, Inc. | 4 | $97 |
| Organon | 5 | $92 |
| Sanofi-aventis U.S. LLC | 1 | $85 |
| Sun Pharmaceutical Industries Inc. | 2 | $44 |
| Almirall LLC | 2 | $44 |
| Boehringer Ingelheim | 2 | $41 |
| Dermavant Sciences, Inc. | 2 | $35 |
| Revance Therapeutics, Inc. | 1 | $27 |
| Krystal Biotech Inc | 1 | $26 |
| Botanix SB Inc | 1 | $16 |
| LNHC, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,203 in reported general payments places this provider in the 50th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 11 | $79,671 |
| Ketoconazole | 26 | $401 |
| Doxycycline Hyclate | 12 | $194 |
Paid to pharmacies, not to this prescriber.
Other dermatology in San Antonio
- William CragunSan Antonio$2.2M
- Emily BeckerSan Antonio$1.2M
- Lindsey FinkleaSan Antonio$435K
- John BrowningSan Antonio$351K
- Vivian BucaySan Antonio$241K
- Annabelle GarciaSan Antonio$215K
- Edward LainAustin$2.5M
- Alpesh DesaiHouston$1.6M
- Craig TellerBellaire$1.3M
- Jennifer CatherDallas$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.